Physiology of the Neuromuscular Junction

  • W. C. Bowman


The process of neuromuscular transmission is conceptually simple, the main basic events having been established and widely accepted for more than 40 years. The neurotransmitter acetylcholine is synthesized within the nerve endings and stored in vesicles. A small, ineffective amount is continuously released spontaneously, mainly from the axoplasm but also from the vesicles. Vesicular release (but not axoplasmic release) is abruptly and greatly accelerated, through a Ca2+-dependent mechanism, by the arrival of a nerve impulse at the nerve endings. The released acetylcholine diffuses across the narrow junctional cleft and combines fleetingly with the nicotinic acetylcholine receptors on the postjunctional membrane of the motor endplate. The consequence is a localized depolarization, the endplate potential, which initiates a propagating action potential that passes around the muscle fibe membrane to trigger the contractile mechanism. Although these basic tenets of the transmission process have been accepted for many years, important advances in detailed knowledge continue to be made through the accelerating developments of new skills and techniques, especially in the fields of molecular biology and electrophysiology. The nicotinic acetylcholine receptors of the neuromuscular junction were the first to be isolated, biochemically and biophysically characterized, reconstituted into artificial bilayers, and cloned and sequenced.


Synaptic Vesicle Neuromuscular Junction Nicotinic Receptor Nerve Impulse Acetylcholine Release 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Prior C, Marshall IG, Parsons SM. The pharmacology of vasamicol: an inhibitor of the vesicular acetylcholine transporter. Gen. Pharmacol. 1992, 23: 1017–1022.PubMedCrossRefGoogle Scholar
  2. 2.
    Parsons SM, Prior C, Marshall IG. Acetylcholine transport, storage and release. Int. Rev. Neurobiol. 1993, 35: 279–390.PubMedCrossRefGoogle Scholar
  3. 3.
    Sudhof TC, Jahn R. Proteins of synaptic vesicles involved in exocytosis and membrane recycling. Neuron 1991; 6: 665–677.PubMedCrossRefGoogle Scholar
  4. 4.
    Geppert M, Bolshakov VY, Siegelbaum SA, Takei K, De Camilli P, Hammer RE, Sudhof TC. The role of Rab3A in neurotransmitter release. Nature 1994 ; 369: 493–497.PubMedCrossRefGoogle Scholar
  5. 5.
    Montecucco D, Shiavo G. Tetanus and botulism neurotoxins: a new group of zinc proteases. Trends in Biochemical Sciences 1993; 18: 324–327.PubMedCrossRefGoogle Scholar
  6. 6.
    Petrenko AG, Perin MS, Davletov BA, Ushkaryov YA, Getterp M, Suchof TC. Binding of synaptotagmin to the a-latrotoxin receptor implicates both in synaptic vesicle exocytosis. Nature 1991; 353: 65–68.PubMedCrossRefGoogle Scholar
  7. 7.
    Leveque C, Hoshino T, David P, Shoji. Kasai Y, Leys K, Omori A, Lang B, Far OE, Sato K, Martin-Martot N, Newson-Davis J, Takahashi M, Seager MJ. The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen. Proc. Nat. Acad. Sci USA 1992, 89: 3625–3629.PubMedCrossRefGoogle Scholar
  8. 8.
    McGuiness TL, Greengard P. Protein phosphorylation and synaptic transmission. In: Sellin LC, Libelius R, Thesleff S, eds. Neuromuscular Junction. Amsterdam: Elsevier 1988;111–124.Google Scholar
  9. 9.
    Vizi ES, Somogyi GT. Prejunctional modulation of acetylcholine release from the skeletal neuromuscular junction: link between positive (nicotinic)- and negative (muscarinic)-feedback modulation. Br. J. Pharmacol. 1989, 97: 65–70.PubMedCrossRefGoogle Scholar
  10. 10.
    Bowman WC, Prior C, Marshall IG. Presynaptic receptors in the neuromuscular junction. Annals N Y Acad Sci. 1990; 604:69–81.CrossRefGoogle Scholar
  11. 11.
    Wessler I. Acetylcholine at motor nerve endings: storage, release, and presynaptic modulation by autoreceptors and adrenoceptors. Int. Rev. Neurobiol. 1992, 34: 283–384.PubMedCrossRefGoogle Scholar
  12. 12.
    Vizi ES, Somogyi GT, Nagashima H, Duncalf D, Chaudhry JA, Kobayashi 0, Goldiner PL, Foldes FF. Tubocurarine and pancuronium inhibit evoked release of acetylcholine from the mouse hemidiaphragm preparation. Br. J. Anaesth. 1987; 59:226–231.PubMedCrossRefGoogle Scholar
  13. 13.
    Braga MFM, Rowan EG, Harvey AL, Bowman WC. Interactions between suxamethonium and non-depolarizing neuromuscular blocking drugs. Br. J. Anaesth. 1994; 72:198–204.PubMedCrossRefGoogle Scholar
  14. 14.
    Kimura I, Okazaki M, Uwano T, Kobayashi S, Kimura M. Succinylcholine-induced acceleration and suppression of electrically-evoked acetylcholine release from mouse phrenic nervehemidiaphragm muscle preparation. Japan J. Pharmacol. 1991; 57:397–403.CrossRefGoogle Scholar
  15. 15.
    Vizi ES, Chaudhry IA, Goldiner PI, Ohta Y, Nagashima H, Foldes FF. The pre- and postjunctional components of the neuromuscular effect of antibiotics. J. Anesth. 1991; 5:1–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Tian L, Prior C, Dempster J, Marshall IG. Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals. J Physiol. 1994; 476: 517–530.PubMedGoogle Scholar
  17. 17.
    Vizi ES. Evidence that catecholamines increase acetylcholine release from neuromuscular junctions through stimulation of alpha-1 adrenoceptors. Naunyn-Schmiedeberg’s Arch. Pharmacol. 1991; 343:435–438.CrossRefGoogle Scholar
  18. 18.
    Nagano O, Foldes FF, Nakatsuka H, Reich D, Ohta Y, Sperlagh B, Vizi ES. Presynaptic A1-purinoceptor-mediated inhibitory effects of adenosine and its stable analogues on the mouse hemidiaphragm preparation. Naunyn-Schmiedeberg’s Arch. Pharmacol. 1992; 346:197–202.CrossRefGoogle Scholar
  19. 19.
    Lu Z, Smith DO. Adenosine 5‣-triphosphate increases acetylcholine channel opening frequency in rat skeletal muscle. J. Physiol. 1991; 436: 45–56.PubMedGoogle Scholar
  20. 20.
    Correia-de-Sa P. Sebastiao AM, Ribeiro J. Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve endings of the rat. Brit. J. Pharmacol. 1991; 103: 1614–1620.CrossRefGoogle Scholar
  21. 21.
    Popper P, Micevych PE. Localization of calcitonin gene-related peptide and its receptors in a striated muscle. Brain Res. 1989; 496: 180–186.PubMedCrossRefGoogle Scholar
  22. 22.
    Fontaine B, Klarsfeld A, Changeux J-P. Calcitonin gene-related peptide and muscle activity regulate acetylcholine receptor a-subunit mRNA levels by distinct intracellular pathways. J. Cell Biol. 1987; 105: 1337–1342.PubMedCrossRefGoogle Scholar
  23. 23.
    Sastry BVR. Nicotinic receptor. Anaesth. Pharmacol. Rev. 1993; 1: 6–19.Google Scholar
  24. 24.
    Unwin N. Neurotransmitter action: opening of ligand-gated ion channels. Cell 72: Neuron 10: Supplement 31–41. 1993.PubMedCrossRefGoogle Scholar
  25. 25.
    Fong TM, McNamee MG. Correlation between acetylcholine receptor function and structural properties of membranes. Biochemistry 1986; 25: 830–840.PubMedCrossRefGoogle Scholar
  26. 26.
    Plomp JJ, van Kempen GThH, Molenaar PC. Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in a-bungarotoxin-treated rats. J. Physiol. 1992; 458: 487–499.PubMedGoogle Scholar

Copyright information

© Springer Japan 1995

Authors and Affiliations

  • W. C. Bowman
    • 1
  1. 1.Department of Physiology & PharmacologyUniversity of StrathclydeGlasgowUK

Personalised recommendations